Abstract
SUMMARY: Neuroradiologists play a key role in brain tumor diagnosis and management. Staying current with the latest classification systems and diagnostic markers is important to provide optimal patient care. Publication of the 2016 World Health Organization Classification of Tumors of the Central Nervous System introduced a paradigm shift in the diagnosis of CNS neoplasms. For the first time, both histologic features and genetic alterations were incorporated into the diagnostic framework, classifying and grading brain tumors. The newly published 2021 World Health Organization Classification of Tumors of the Central Nervous System, May 2021, 5th edition, has added even more molecular features and updated pathologic diagnoses. We present, summarize, and illustrate the most salient aspects of the new 5th edition. We have selected the key “must know” topics for practicing neuroradiologists.
ABBREVIATIONS:
- DGONC
- diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters
- EPN
- ependymoma
- ETMR
- embryonal tumor with multilayered rosettes
- FISH
- fluorescence in situ hybridization
- NEC
- not elsewhere classified; NOS = not otherwise specified
- MB
- medulloblastoma
- MGNT
- myxoid glioneuronal tumor
- MVNT
- multinodular and vacuolating neuronal tumor
- PF
- posterior fossa
- SC
- spinal cord
- ST
- supratentorial
- WHO
- World Health Organization
- IDH
- isocitrate dehydrogenase
Footnotes
Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org.
- © 2022 by American Journal of Neuroradiology
Indicates open access to non-subscribers at www.ajnr.org